Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
about
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
description
scientific article published on 24 January 2020
@en
name
Autologous monocyte-derived DC ...... tive, randomized phase 2 trial
@en
type
label
Autologous monocyte-derived DC ...... tive, randomized phase 2 trial
@en
prefLabel
Autologous monocyte-derived DC ...... tive, randomized phase 2 trial
@en
P2093
P50
P1476
Autologous monocyte-derived DC ...... tive, randomized phase 2 trial
@en
P2093
Alexandra Croockewit
Anna de Goede
Lieke L van der Woude
Marieke Welzen
Michelle M van Rossum
Stanleyson V Hato
Winette T A van der Graaf
P304
P356
10.1007/S00262-019-02466-X
P50
P577
2020-01-24T00:00:00Z